Nano-Silver Fluoride
Nano-Silver Fluoride is a pharmaceutical drug with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
1
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Efficacy of Silver Diamine Fluoride Versus Nano-Silver Fluoride in Arresting Active Dentin Caries in Primary Teeth in Young Children
The Desensitising Effect of Nanosilver Fluoride in Molar-Incisor Hypomineralisation
Comparison of Cariostatic Effect of Nano-Silver Fluoride Versus Silver Diamine Fluoride
Remineralization of Dentine Caries Using Two Remineralizing Agents Which Are Nanosilver Fluoride and Casein phosphopeptides_amorphous Calcium Phosphate
Nanosilver Fluoride to Prevent Dental Biofilms Growth
Clinical Trials (5)
Efficacy of Silver Diamine Fluoride Versus Nano-Silver Fluoride in Arresting Active Dentin Caries in Primary Teeth in Young Children
The Desensitising Effect of Nanosilver Fluoride in Molar-Incisor Hypomineralisation
Comparison of Cariostatic Effect of Nano-Silver Fluoride Versus Silver Diamine Fluoride
Remineralization of Dentine Caries Using Two Remineralizing Agents Which Are Nanosilver Fluoride and Casein phosphopeptides_amorphous Calcium Phosphate
Nanosilver Fluoride to Prevent Dental Biofilms Growth
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5